This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Molecular Partners Ag. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Nicolo Rigamonti: Innovator in Multispecific Proteins
Introduction
Nicolo Rigamonti is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific proteins. His work focuses on creating innovative solutions for medical applications, especially in the treatment of diseases such as cancer.
Latest Patents
Nicolo Rigamonti holds a patent for multispecific proteins that comprise designed ankyrin repeat domains with binding specificity for different targets, including CD40 and FAP. This patent also encompasses nucleic acids encoding these proteins, pharmaceutical compositions that include them, and their use in diagnosing and treating diseases in mammals, including humans.
Career Highlights
Nicolo is associated with Molecular Partners AG, a company known for its cutting-edge research in the field of biopharmaceuticals. His work at the company has positioned him as a key player in the development of novel therapeutic strategies.
Collaborations
He collaborates with talented individuals such as Clara Domke and Valérie Perrine Calabro, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Nicolo Rigamonti's contributions to the field of multispecific proteins highlight his role as an influential inventor in biotechnology. His work continues to pave the way for advancements in medical treatments and diagnostics.